Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis
出版年份 2020 全文链接
标题
Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis
作者
关键词
-
出版物
Current Atherosclerosis Reports
Volume 22, Issue 9, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-25
DOI
10.1007/s11883-020-00867-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
- (2020) Sotirios Tsimikas et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 and Cardiovascular Disease
- (2020) Kevin J. Clerkin et al. CIRCULATION
- Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease
- (2020) Susanna C. Larsson et al. CIRCULATION
- Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
- (2020) Johan G. Schnitzler et al. CIRCULATION RESEARCH
- COVID-19 and the Heart
- (2020) Akbarshakh Akhmerov et al. CIRCULATION RESEARCH
- Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China
- (2020) Chor-Cheung Frankie Tam et al.
- Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
- (2020) Jie Ma et al. CLINICAL IMMUNOLOGY
- Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)
- (2020) Lotte C A Stiekema et al. EUROPEAN HEART JOURNAL
- Plasma kinetics of mature PCSK9, furin-cleaved PCSK9, and Lp(a) with or without administration of PCSK9 inhibitors in acute myocardial infarction
- (2020) Akihiro Nakamura et al. Journal of Cardiology
- Incidence of venous thromboembolism in hospitalized patients with COVID‐19
- (2020) Saskia Middeldorp et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Lupus anticoagulant is frequent in patients with Covid‐19
- (2020) Inès Harzallah et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Why tocilizumab could be an effective treatment for severe COVID-19?
- (2020) Binqing Fu et al. Journal of Translational Medicine
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- (2020) Yan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
- (2020) Thomas J. Oxley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Does apolipoprotein E genotype predict COVID-19 severity?
- (2020) M R Goldstein et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
- (2020) Tao Chen et al. BMJ-British Medical Journal
- Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations
- (2020) Enrico M. Marone et al. Journal of Vascular Surgery-Venous and Lymphatic Disorders
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
- (2020) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
- (2020) Richard T. Eastman et al. ACS Central Science
- African-American COVID-19 Mortality
- (2020) Keith C. Ferdinand et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Statin therapy increases lipoprotein(a) levels
- (2019) Sotirios Tsimikas et al. EUROPEAN HEART JOURNAL
- Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells
- (2019) Claus Rieker et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein Apheresis for Lipoprotein(a) and Cardiovascular Disease
- (2019) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis
- (2019) Xiaoli Sun et al. Cell Metabolism
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
- (2018) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice
- (2018) Xuchu Que et al. NATURE
- Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial
- (2017) Tina Z. Khan et al. EUROPEAN HEART JOURNAL
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein (a) as an Acute Phase Reactant in Patients on Chronic Hemodialysis
- (2017) Valdete Topçiu-Shufta et al. Bosnian Journal of Basic Medical Sciences
- Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United StatesHighlights
- (2016) Steve Varvel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansClinical Perspective
- (2016) Fleur M. van der Valk et al. CIRCULATION
- Lipoprotein (a) as a risk factor for ischemic stroke: A meta-analysis
- (2015) Alexander H. Nave et al. ATHEROSCLEROSIS
- Lipoprotein(a): Its relevance to the pediatric population
- (2015) Catherine J. McNeal Journal of Clinical Lipidology
- IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans
- (2015) Nike Müller et al. JOURNAL OF LIPID RESEARCH
- Release and Capture of Bioactive Oxidized Phospholipids and Oxidized Cholesteryl Esters During Percutaneous Coronary and Peripheral Arterial Interventions in Humans
- (2014) Amir Ravandi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)
- (2013) Gregor Leibundgut et al. JOURNAL OF LIPID RESEARCH
- Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism
- (2012) Anna Helgadottir et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Oxidation-Specific Biomarkers, Prospective 15-Year Cardiovascular and Stroke Outcomes, and Net Reclassification of Cardiovascular Events
- (2012) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association between the Interleukin-6 Promoter Polymorphism −174G/C and Serum Lipoprotein(a) Concentrations in Humans
- (2011) Heiner K. Berthold et al. PLoS One
- Acute infection with Epstein–Barr virus is associated with atherogenic lipid changes
- (2010) F. Apostolou et al. ATHEROSCLEROSIS
- Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases
- (2010) Olaf Schultz et al. PLoS One
- Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury
- (2008) Yumiko Imai et al. CELL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started